41/1105/2026 Medication Ritonavir - SPMS

This tender, identified by reference 41/1105/2026, concerns the procurement of the medication Ritonavir. SPMS (Serviços Partilhados do Ministério da Saúde), the shared services entity for the Portuguese Ministry of Health, is managing this procurement. Ritonavir is an antiretroviral medication, often used in combination with other drugs, to treat HIV/AIDS. It can also be used as a pharmacokinetic enhancer (booster) for certain other protease inhibitors, increasing their effectiveness. This procurement is crucial for ensuring the continued availability of Ritonavir for patients undergoing HIV treatment within the Portuguese public healthcare system. The tender will specify the required quantities, dosage forms (e.g., capsules, oral solution), packaging details, and delivery timelines. SPMS centralizes such procurements to achieve better pricing and ensure a stable supply of essential medicines across the country.

This is a supplies contract in the health and medical services, information and communication technology and general supplies sectors, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 179.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.